Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1.

Source:http://linkedlifedata.com/resource/pubmed/id/17404107

Clin. Cancer Res. 2007 Apr 1 13 7 2226-35

Download in:

View as

Triples

General Info

PMID
17404107